Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03915574 · ClinicalTrials.gov registry record · NA

Dural Puncture Epidural Versus Epidural Anesthesia for Cesarean Delivery

A NA study, sponsored by University of Arkansas.

Completed
Registry status
NA
Development phase
280
Enrollment target

NCT03915574: Completed NA study, sponsored by University of Arkansas.

NCT03915574 is a NA study that has completed, run by University of Arkansas. The registered enrollment target is 280 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03915574, a NA study, has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
NA
Development phase
280 participants
Enrollment target

Study Summary

This study will compare two anesthetics techniques called Dural Puncture Epidural (DPE) and Standard Epidural as to which of the two can provide faster and potentially better at providing pain relief for cesarean sections. It will also compare these two anesthetics techniques on the percentage of women who require additional drugs to control pain during their cesarean deliveries. The results of this study will help anesthesiologists know which anesthetic technique can provide faster and potentially better at providing pain relief for cesarean sections.

Primary Outcome

The primary outcome will be the onset time of surgical anesthesia in seconds. This will be measured from the induction of anesthesia (as defined by the beginning of injection of the "Induction 1 syringe") to the point at which sharp sensation is lost bilaterally at the T6 dermatomal level (as measured by a blunt plastic neurotip® (Owen Mumford, USA) device)

Interventions

  • DEVICE 25G Dural Puncture Epidural
  • DEVICE Standard Epidural

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2019-05-09
Est. Completion 2023-04-01
Phase NA
University of Arkansas

318 total trials

What the finished NCT03915574 record still lists

NCT03915574 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).

The record links to 0 conditions, and to 2 interventions - of which 25G Dural Puncture Epidural is the first listed.

NCT03915574 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03915574 about?

NCT03915574 is a clinical study titled "Dural Puncture Epidural Versus Epidural Anesthesia for Cesarean Delivery". This study will compare two anesthetics techniques called Dural Puncture Epidural (DPE) and Standard Epidural as to which of the two can provide faster and potentially better at providing pain relief for cesarean sections. It will also compare these two anesthetics techniques on the percentage of wo...

What is the current status of trial NCT03915574?

This trial is currently completed. It is a NA study. The enrollment target is 280 participants. The study started on 2019-05-09. Estimated completion is 2023-04-01.

What interventions are being tested in trial NCT03915574?

The interventions under investigation include: 25G Dural Puncture Epidural (DEVICE), Standard Epidural (DEVICE).

Who is sponsoring clinical trial NCT03915574?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03915574's enrollment target sits among peer trials

280 380th of 2000 higher than 1,620 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04084730 · 280 participants · Phase 2

    Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

  • NCT04518657 · 280 participants · NA

    Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis

  • NCT04634916 · 280 participants · NA

    Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

  • NCT04829617 · 280 participants · NA

    Promoting Well-being and Health in Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03915574, the US trial registry maintained by the National Library of Medicine. NCT03915574 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.